PRAXIS PRECISION MEDICINES I's ticker is PRAX and the CUSIP is 74006W108. A total of 79 filers reported holding PRAXIS PRECISION MEDICINES I in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,170 | +48.7% | 21,152 | 0.0% | 0.00% | – |
| Q2 2023 | $24,325 | -76.7% | 21,152 | -83.6% | 0.00% | – |
| Q1 2023 | $104,600 | -60.2% | 129,296 | +17.2% | 0.00% | – |
| Q4 2022 | $262,664 | +36.8% | 110,363 | +31.1% | 0.00% | – |
| Q3 2022 | $192,000 | -69.7% | 84,185 | -67.4% | 0.00% | – |
| Q2 2022 | $633,000 | -75.6% | 258,316 | +1.6% | 0.00% | -100.0% |
| Q1 2022 | $2,596,000 | -46.8% | 254,175 | +2.6% | 0.00% | 0.0% |
| Q4 2021 | $4,881,000 | +10.9% | 247,761 | +4.1% | 0.00% | 0.0% |
| Q3 2021 | $4,400,000 | +101.0% | 237,915 | +98.7% | 0.00% | 0.0% |
| Q2 2021 | $2,189,000 | -8.0% | 119,719 | +64.8% | 0.00% | 0.0% |
| Q1 2021 | $2,380,000 | -38.0% | 72,648 | +4.1% | 0.00% | -50.0% |
| Q4 2020 | $3,839,000 | – | 69,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,469,665 | $3,497,803 | 4.70% |
| Ally Bridge Group (NY) LLC | 630,584 | $1,500,790 | 1.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,855,989 | $6,797,254 | 1.35% |
| 72 Investment Holdings, LLC | 988,995 | $2,353,808 | 1.08% |
| MPM BioImpact LLC | 610,000 | $1,451,800 | 0.38% |
| Octagon Capital Advisors LP | 800,000 | $1,904,000 | 0.30% |
| PFM Health Sciences, LP | 2,777,467 | $6,610,371 | 0.24% |
| HARVARD MANAGEMENT CO INC | 778,517 | $1,852,870 | 0.23% |
| Eventide Asset Management | 3,518,062 | $8,372,988 | 0.16% |
| Artal Group S.A. | 1,200,000 | $2,856 | 0.16% |